Neutralizing Monoclonal Anti-SARS-CoV-2 Antibodies Isolated from Immunized Rabbits Define Novel Vulnerable Spike-Protein Epitope

Monoclonal antibodies represent an important avenue for COVID-19 therapy and are routinely used for rapid and accessible diagnosis of SARS-CoV-2 infection. The recent emergence of SARS-CoV-2 genetic variants emphasized the need to enlarge the repertoire of antibodies that target diverse epitopes, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Makdasi, Efi, Levy, Yinon, Alcalay, Ron, Noy-Porat, Tal, Zahavy, Eran, Mechaly, Adva, Epstein, Eyal, Peretz, Eldar, Cohen, Hila, Bar-On, Liat, Chitlaru, Theodor, Cohen, Ofer, Glinert, Itai, Achdout, Hagit, Israely, Tomer, Rosenfeld, Ronit, Mazor, Ohad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065470/
https://www.ncbi.nlm.nih.gov/pubmed/33810465
http://dx.doi.org/10.3390/v13040566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065470/
https://www.ncbi.nlm.nih.gov/pubmed/33810465
http://dx.doi.org/10.3390/v13040566

Ejemplares similares